Evidence map›Paper›PMID 36149768›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2022

Interleukin 4/13 signaling in cardiac regeneration and repair.

Amirala Bakhshian Nik, Santiago Alvarez-Argote, Caitlin C O'Meara

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. CD206Circulation · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Global IL4Rα blockade exacerbates heart failure after an ischemic event in mice and humans.American journal of physiology. Heart and circulatory physiology · 2024
    Observational
  14. Article
  15. Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular Impacts.International journal of chronic obstructive pulmonary disease · 2024
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amirala Bakhshian NikDepartment of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0002-1176-1628
Santiago Alvarez-ArgoteDepartment of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0001-6082-0789
Caitlin C O'MearaDepartment of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0002-9212-0821
Medical College of Wisconsin · US

Funding

IL13 - A Novel Therapeutic Factor for Cardiac RegenerationR01HL141159 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI O'MEARA, CAITLIN C · 2019 to 2023
$2.1M
Genetic mapping of variable cardiac cell composition in the ratR21HL156022 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI O'MEARA, CAITLIN C, PATTERSON, MICHAELA · 2021 to 2022
$443k
NHLBI NIH HHS R01 HL141159NHLBI NIH HHS R21 HL156022
6 · The paper itself

Abstract

Interleukin 4 (IL4) and interleukin 13 (IL13) are closely related cytokines that have been classically attributed to type II immunity, namely, differentiation of T-helper 2 (T

Indexed as

Interleukin-13Interleukin-4AnimalsCytokinesHeartMammalsRegenerationCytokinesInterleukin-13Interleukin-4interleukinmyocardial infarctionregeneration

Identifiers

PMID36149768
PMCPMC9602781
OpenAlexW4296797653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.